Oliver Planz News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Oliver planz. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Oliver Planz Today - Breaking & Trending Today

Atriva Therapeutics announces efficacy of its lead compound zapnometinib against Omicron

28.03.2022 Atriva Therapeutics announces efficacy of its lead compound zapnometinib against Omicron | Atriva | COVID-19 | Omicron | variants ....

Oliver Planz , Eva Bauer Raimund Gabriel , Stephan Stenglein , Rainer Lichtenberger , Eli Lilly , Mc Services , Atriva Therapeutics , Therapeutics Gmbh , While Omicron , Investor Relations , Covid 19 ,

Atriva receives FDA Orphan Drug Designation for Zapnometinib to treat Hantavirus Infections

10.01.2022 Atriva receives FDA Orphan Drug Designation for Zapnometinib to treat Hantavirus Infections | Atriva Therapeutics | FDA ODD ....

Eva Bauer Raimund Gabriel , Oliver Planz , Rainer Lichtenberger , Mc Services , Drug Administration , Atriva Therapeutics , Drug Designation , Therapeutics Gmbh , Orphan Drug Designation , Hantavirus Pulmonary Syndrome , Hemorrhagic Fever , Renal Syndrome , Pulmonary Syndrome , Investor Relations , Da Odd , First In Class , Ost Targeting Small Molecule , Orphan Drug Designation ,

New vaccination method aims at comprehensive protection against all known influenza mutations

New vaccination method aims at comprehensive protection against all known influenza mutations
One shot, protected forever: This would be a dream come true regarding influenza vaccinations. So far, vaccination against influenza did not provide a lasting protection. The reason: Influenza viruses mutate very fast. Every year, new virus strains emerge against which previous vaccinations provide no or only limited protection. To avoid having to vaccinate against the flu every year, a research network consisting of the University of Konstanz, the University of Tübingen and Technische Universität Dresden is testing an alternative vaccination method. This new method aims at comprehensive protection against all known influenza mutations and thus is a promising candidate for reaching lasting immunity. ....

Baden Wuberg , Oliver Planz , Marcus Groettrup , Technische Universit , Peter Martus , Jacques Rohayem Technische Universit , Emily Henderson , Jacques Rohayem , Klinische Epidemiologie , Professor Peter Martus University Hospital , Interfaculty Institute For Cell Biology , University Hospital Of Tuebingen , Professor Marcus Groettrup University Of Konstanz , University Of Konstanz , Ministry Of Education , Professor Oliver Planz University , Professor Marcus Groettrup , Federal Ministry , Professor Oliver Planz , Professor Peter Martus , University Hospital , Professor Jacques Rohayem , Interfaculty Institute , Cell Biology , Clinical Trial , Electron Microscopy ,

A general influenza vaccine

E-Mail
IMAGE: Biodegradable microspheres that are produced via spray drying. They contain an influenza virus antigen and an immunostimulating substance. The image was obtained by electron microscopy, enlarged 3,000 times.
Copyright: Dennis.
view more
Credit: Dennis Horvath, University of Konstanz
One shot, protected forever: This would be a dream come true regarding influenza vaccinations. So far, vaccination against influenza did not provide a lasting protection. The reason: Influenza viruses mutate very fast. Every year, new virus strains emerge against which previous vaccinations provide no or only limited protection. To avoid having to vaccinate against the flu every year, a research network consisting of the University of Konstanz, the University of Tübingen and Technische Universität Dresden is testing an alternative vaccination method. This new method aims at comprehensive protection against all known influenza mutations and thus is a pro ....

Baden Wuberg , Oliver Planz , Dennis Horvath , Marcus Groettrup , Technische Universit , Peter Martus , Jacques Rohayem Technische Universit , Jacques Rohayem , Klinische Epidemiologie , Professor Peter Martus University Hospital , Interfaculty Institute For Cell Biology , University Hospital Of Tuebingen , Professor Marcus Groettrup University Of Konstanz , University Of Konstanz , Ministry Of Education , Professor Oliver Planz University , Professor Marcus Groettrup , Federal Ministry , Professor Oliver Planz , Professor Peter Martus , University Hospital , Professor Jacques Rohayem , Interfaculty Institute , Cell Biology , Health Care , Medicine Health ,